Loading clinical trials...
Loading clinical trials...
This Post-Market Clinical Follow-Up study aims to document the success and survival of the Axiom® BL X3 Implants up to 3 years after loading.
The total study duration for each patient should be 3 years after loading. . The investigational devices are CE-(Conformité Européenne, meaning European Conformity) marked product. 14 centers will participate in France Implants used are Axiom® BL X3 with lengths ranging from 6.5 to 18 mm and diameters ranging from 3.4 to 6.4 mm. The study and any amendments will be performed as far as possible according to International Organization for Standardization (ISO) 14155, 21CFR 820 for FDA requirement and conform to the Declaration of Helsinki (last revision Fortaleza 2013) and local legal and regulatory requirements.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Cabinet Dentaire Les Aravis
Annecy, France
Cabinet Dr Fumery
Beauvais, France
Cabinet Dr Vigouroux
Cadaujac, France
Cabinet dentaire Octogone
Draguignan, France
Cabinet dentaire Dr Murcia
Le Bouscat, France
Cabinet Dentaire Patrice Margossian
Marseille, France
Cabinet Dr Bruet
Moulins, France
Cabinet Dr Gris
Royan, France
Cabinet Dr Soriano
Saint-Jeoire, France
Cabinet Dr Monnot
Sallanches, France
Start Date
April 5, 2023
Primary Completion Date
August 20, 2025
Completion Date
July 1, 2027
Last Updated
March 19, 2025
200
ESTIMATED participants
Axiom BL X3
DEVICE
Lead Sponsor
Anthogyr
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02047591